|
|
Volumn 89, Issue 1, 2002, Pages 4-5
|
|
Aspirin resistance
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ADENOSINE DIPHOSPHATE;
ANTITHROMBOCYTIC AGENT;
COLLAGEN;
GLYCOPROTEIN IIIA;
INTEGRIN;
MEMBRANE RECEPTOR;
BLEEDING;
BLOOD LEVEL;
CEREBROVASCULAR DISEASE;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG EFFECT;
HEART DISEASE;
HEART MUSCLE ISCHEMIA;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HIGH RISK POPULATION;
HUMAN;
LONG TERM CARE;
PERIPHERAL VASCULAR DISEASE;
PRIORITY JOURNAL;
PROPHYLAXIS;
PROTEIN POLYMORPHISM;
REDUCTION;
RISK FACTOR;
SHORT SURVEY;
THROMBOCYTE;
THROMBOCYTE AGGREGATION;
THROMBOCYTE FUNCTION;
TREATMENT OUTCOME;
ASPIRIN;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
DRUG RESISTANCE;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
|
|
EID: 0036135221
PISSN: 00071323
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0007-1323.2001.01971.x Document Type: Short Survey |
|
Times cited : (21)
|
|
References (11)
|
